College Women Have Used GLP-1 Drugs for Weight Loss

Young adults are increasingly turning to GLP-1 medications to meet thinness ideals during social recruitment events.

Updated on Sept. 20, 2026 in Weight Loss

Gouache-painted illustration of a single empty medicine vial and a silk ribbon, depicting the pressure of weight-loss trends.
Young adults are increasingly using GLP-1 weight-loss medications to meet societal beauty ideals during high-pressure social recruitment events on US college campuses. AI Illustration. Upload story photo >

Live Poll

Is the pressure to look thin causing unnecessary use of medical weight-loss drugs?

College students are reportedly using GLP-1 weight-loss medications to achieve thin beauty standards during sorority recruitment. Peer-driven weight loss competitions and social media pressure appear to be fueling the trend on campuses across the country.

Why it matters

The pursuit of rapid weight loss before social milestones highlights how beauty ideals influence medical choices among young adults. This trend carries significant health risks, as many students may not be aware of the specific pharmacological interactions these medications can pose.

A 2024 JAMA analysis found that 162,439 young adults ages 18 to 25 received at least one GLP-1 prescription in 2023, with women accounting for 76.4% of those patients.

The players

JAMA

The Journal of the American Medical Association is a peer-reviewed medical journal that publishes original research and clinical studies.

Monitoring the Future

This is a long-term research program that conducts annual surveys to track the behaviors, attitudes, and values of American students.

The details

Students are increasingly utilizing compounded medications to achieve weight loss during high-pressure sorority recruitment processes. Tirzepatide usage, for instance, can reduce the effectiveness of oral hormonal contraceptives, while labeling for drugs like Wegovy advises patients to cease use months before a planned pregnancy.

Timeline

  1. A JAMA analysis of GLP-1 usage among young adults was published in 2024.

  2. A total of 162,439 young adults received GLP-1 prescriptions in 2023.

  3. Data from the Monitoring the Future survey was released in 2025.

The Big Picture

This trend of cosmetic GLP-1 usage contradicts the established clinical safety protocols outlined in the FDA-approved labeling for Wegovy and similar medications.

The use of these medications without medical supervision or during critical hormonal periods can lead to unexpected health complications. Individuals considering these drugs should consult a healthcare provider to discuss potential risks, including hormonal contraceptive interference.

The takeaway

Using potent prescription medications for cosmetic purposes can lead to serious and unforeseen medical consequences. It is essential to prioritize long-term physical health over short-term aesthetic goals during high-stress life events.

Further reading

For more information on medical guidelines, visit the Weight Loss section.

Live Poll

Is the pressure to look thin causing unnecessary use of medical weight-loss drugs?